Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Systemically dispersed innate IL-13-expressing cells in type 2 immunity.

Type 2 immunity is a stereotyped host response to allergens and parasitic helminths that is sustained in large part by the cytokines IL-4 and IL-13. Recent advances have called attention to the contributions by innate cells in initiating adaptive immunity, including a novel lineage-negative population of cells that secretes IL-13 and IL-5 in response to the epithelial cytokines IL-25 and IL-33. Here, we use IL-4 and IL-13 reporter mice to track lineage-negative innate cells that arise during type 2 immunity or in response to IL-25 and IL-33 in vivo. Unexpectedly, lineage-negative IL-25 (and IL-33) responsive cells are widely distributed in tissues of the mouse and are particularly prevalent in mesenteric lymph nodes, spleen, and liver. These cells expand robustly in response to exogenous IL-25 or IL-33 and after infection with the helminth Nippostrongylus brasiliensis, and they are the major innate IL-13-expressing cells under these conditions. Activation of these cells using IL-25 is sufficient for worm clearance, even in the absence of adaptive immunity. Widely dispersed innate type 2 helper cells, which we designate Ih2 cells, play an integral role in type 2 immune responses.

Pubmed ID: 20534524 RIS Download

Mesh terms: Animals | Cell Lineage | Cytokines | Eosinophils | Immune System | Immunity, Innate | Interleukin-13 | Interleukin-33 | Interleukin-4 | Interleukins | Lymph Nodes | Mice | Mice, Inbred C57BL | Mice, Transgenic | Nippostrongylus

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, Id: R01 HL085089
  • Agency: NIAID NIH HHS, Id: R01 AI026918
  • Agency: NIAID NIH HHS, Id: U19 AI077439
  • Agency: Howard Hughes Medical Institute, Id: AI26918
  • Agency: NIAID NIH HHS, Id: R37 AI026918
  • Agency: NIAID NIH HHS, Id: HL085089
  • Agency: NHLBI NIH HHS, Id: R01 AI030663
  • Agency: NIAID NIH HHS, Id:

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.